DAM
TEVA icon

DLD Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

DLD Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-43,200
Closed -$819K – 117
2017
Q4 		$819K Buy
43,200
+21,600
+100% +$325K 0.06% 50
2017
Q3 		$380K Buy
+21,600
New +$486K 0.04% 69

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DLD Asset Management's TEVA Position: Q4 2017 in Review

DLD Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 83,900 shares — an estimated $1.26M sold.

DLD Asset Management first reported a position in TEVA in Q3 2017 and held it in 1 quarter. The position peaked at $1.48M in Q3 2017. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • DLD Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • DLD Asset Management sold 83,900 Teva Pharmaceuticals shares in Q4 2017, an estimated $1.26M.
  • DLD Asset Management first reported a position in Teva Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • DLD Asset Management's Teva Pharmaceuticals position peaked at $1.48M in Q3 2017.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.